Related Experiment Video
Updated: Sep 26, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary
Jeffrey T-J Huang1, Erin Cant2, Holly R Keir2
1Division of Systems Medicine and.
Patients with the COPD-bronchiectasis association exhibit distinct sputum microbiome and proteome profiles, characterized by neutrophilic inflammation and Gram-negative infections. These findings help differentiate this condition from chronic obstructive pulmonary disease (COPD) alone.
Area of Science:
- Respiratory Medicine
- Microbiome Research
- Proteomics
Background:
- Bronchiectasis and chronic obstructive pulmonary disease (COPD) frequently co-occur, forming the
Purpose of the Study:
- Investigate sputum microbiome and proteome in COPD, bronchiectasis, and their association.
- Identify distinct endotypes for targeted treatment strategies.
Main Methods:
- 16S rRNA sequencing and label-free proteomics on sputum samples.
- Validation in an independent cohort using targeted inflammatory markers, mucins, and bacterial culture.
Main Results:
- Partial separation of microbiome and proteome profiles between COPD and COPD-bronchiectasis association groups.
- COPD-bronchiectasis association shows higher Proteobacteria, MUC5AC, and neutrophil degranulation pathway proteins.
- COPD exhibits higher MUC5B, peptidase inhibitors, commensal taxa, and microbiome diversity.
- Overlapping profiles observed between COPD-bronchiectasis association and bronchiectasis groups.
Conclusions:
- The COPD-bronchiectasis association is characterized by neutrophilic inflammation, specific mucin expression patterns (MUC5AC), and Gram-negative infections.
- Five distinct endotypes identified with unique inflammatory, mucin, and microbiological features.
- Findings validated in an independent cohort, supporting distinct disease traits.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

